Agilon Financial Statements From 2010 to 2024

AGL Stock  USD 6.90  0.02  0.29%   
Agilon Health financial statements provide useful quarterly and yearly information to potential agilon health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Agilon Health financial statements helps investors assess Agilon Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Agilon Health's valuation are summarized below:
Gross Profit
112.3 M
Profit Margin
(0.06)
Market Capitalization
2.8 B
Enterprise Value Revenue
0.368
Revenue
4.9 B
There are over one hundred nineteen available fundamental signals for agilon health, which can be analyzed over time and compared to other ratios. We recommend to validate Agilon Health's prevailing fundamental drivers against the all of the trends between 2010 and 2024.

Agilon Health Total Revenue

2.39 Billion

Check Agilon Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agilon Health's main balance sheet or income statement drivers, such as Tax Provision of 936.1 K, Interest Income of 5.6 M or Discontinued Operations of 561.5 K, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0 or PTB Ratio of 8.14. Agilon financial statements analysis is a perfect complement when working with Agilon Health Valuation or Volatility modules.
  
Check out the analysis of Agilon Health Correlation against competitors.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.

Agilon Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.3 B1.7 B719.4 M
Slightly volatile
Short and Long Term Debt Total47.3 M52.3 M69.6 M
Slightly volatile
Other Current LiabilitiesB970.9 M185.1 M
Slightly volatile
Total Current Liabilities513.8 M977.2 M309.7 M
Slightly volatile
Other Liabilities62.8 M66.1 M292.5 M
Slightly volatile
Property Plant And Equipment Net23.1 M41 M19.8 M
Slightly volatile
Accounts Payable505.7 M968.1 M299.9 M
Slightly volatile
Cash108.6 M114.3 M206.9 M
Slightly volatile
Non Current Assets Total227.8 M260.8 M178.6 M
Slightly volatile
Non Currrent Assets Other82.9 M87.1 M46.1 M
Slightly volatile
Other Assets0.951.040.3 M
Pretty Stable
Long Term Debt39.4 M32.3 M59.3 M
Slightly volatile
Cash And Short Term Investments588.4 M495.1 M291.7 M
Slightly volatile
Net Receivables989.6 M942.5 M253.3 M
Slightly volatile
Good Will30.4 M24.1 M39.6 M
Slightly volatile
Common Stock Total Equity3.6 M4.7 M2.9 M
Slightly volatile
Common Stock Shares Outstanding439.7 M408.9 M397.1 M
Slightly volatile
Long Term Debt Total42.7 M34.6 M59.7 M
Slightly volatile
Liabilities And Stockholders Equity1.3 B1.7 B719.4 M
Slightly volatile
Non Current Liabilities Total201.9 M102.7 M358.7 M
Slightly volatile
Capital Surpluse1.3 B2.4 B712.7 M
Slightly volatile
Capital Lease Obligations9.2 M10.9 M8.1 M
Slightly volatile
Inventory12.8 M12.2 M2.4 M
Slightly volatile
Other Current Assets30.4 M42.5 M19.1 M
Slightly volatile
Other Stockholder Equity1.5 BB695.7 M
Slightly volatile
Total Liabilities791.4 M1.1 B673.5 M
Slightly volatile
Property Plant And Equipment Gross35.6 M55.3 M24.5 M
Slightly volatile
Short and Long Term Debt4.9 M6.2 M3.6 M
Slightly volatile
Total Current Assets1.1 B1.5 B540.8 M
Slightly volatile
Capital Stock3.8 M4.1 M2.9 M
Slightly volatile
Non Current Liabilities Other60.5 M59.5 M69.1 M
Pretty Stable
Cash And Equivalents486.1 M571.6 M262.5 M
Slightly volatile
Net Working Capital550.6 M502.9 M231.1 M
Slightly volatile
Short Term Debt5.5 M9.1 M3.9 M
Slightly volatile
Intangible Assets51 M63.8 M67.3 M
Slightly volatile
Common Stock3.8 M4.1 M2.9 M
Slightly volatile
Property Plant Equipment12.8 M18 M17.6 M
Slightly volatile
Long Term Investments47 M44.8 M14 M
Slightly volatile

Agilon Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income5.6 M4.1 M7.9 M
Slightly volatile
Depreciation And Amortization16.5 M20.2 M33.4 M
Slightly volatile
Interest Expense5.5 M6.7 M8.1 M
Slightly volatile
Selling General Administrative268.5 M285.8 M173 M
Slightly volatile
Total Revenue2.4 B4.3 B1.4 B
Slightly volatile
Gross Profit80.3 M53.6 M46.8 M
Slightly volatile
Other Operating Expenses4.8 B4.5 B1.5 B
Slightly volatile
Cost Of Revenue2.3 B4.3 B1.3 B
Slightly volatile
Total Operating Expenses277.4 M285.6 M183.6 M
Slightly volatile
Reconciled Depreciation16.5 M18.9 M32.8 M
Slightly volatile
Selling And Marketing Expenses150.4 K169.2 K184.2 K
Slightly volatile

Agilon Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation88.5 M69.5 M35.8 M
Slightly volatile
Begin Period Cash Flow416.6 M475.9 M201 M
Slightly volatile
Depreciation16.7 M20.2 M32.9 M
Slightly volatile
Capital Expenditures18.3 M30.8 M9.1 M
Slightly volatile
Change To Operating Activities84.5 M90.8 M55 M
Slightly volatile
Issuance Of Capital Stock13.1 M13.8 M204.4 M
Very volatile
End Period Cash Flow108.6 M114.3 M225.4 M
Slightly volatile
Change To Liabilities31.6 M61.9 M25 M
Slightly volatile
Change To Inventory194.3 M234.8 M161.4 M
Slightly volatile
Cash Flows Other Operating91.8 M105.8 M79.3 M
Slightly volatile
Dividends Paid5.5 M6.2 M6.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.131.188911.54
Slightly volatile
Days Sales Outstanding46.6179.696348.2364
Slightly volatile
Stock Based Compensation To Revenue0.03170.01610.0193
Slightly volatile
EV To Sales1.121.174611.451
Slightly volatile
Inventory Turnover196220240
Slightly volatile
Days Of Inventory On Hand1.411.340.2828
Slightly volatile
Payables Turnover3.634.40344.1952
Slightly volatile
Sales General And Administrative To Revenue0.06290.06620.1412
Slightly volatile
Average Inventory4.2 M4.8 M5.2 M
Slightly volatile
Cash Per Share1.061.21080.7023
Slightly volatile
Capex To Operating Cash Flow0.210.19730.0779
Slightly volatile
Days Payables Outstanding89.0382.890986.7464
Slightly volatile
Income Quality0.580.80080.5019
Slightly volatile
Intangibles To Total Assets0.0480.05050.2167
Slightly volatile
Net Debt To EBITDA0.280.29281.0545
Slightly volatile
Current Ratio1.661.51471.5413
Slightly volatile
Receivables Turnover7.34.57997.8125
Slightly volatile
Graham Number3.164.37622.7139
Slightly volatile
Revenue Per Share11.0810.55563.7531
Slightly volatile
Interest Debt Per Share0.180.11750.1975
Slightly volatile
Debt To Assets0.02260.02380.1467
Slightly volatile
Operating Cycle46.8579.696348.3519
Slightly volatile
Days Of Payables Outstanding89.0382.890986.7464
Slightly volatile
Ebt Per Ebit1.10.83841.0524
Slightly volatile
Quick Ratio1.581.47121.4149
Slightly volatile
Dividend Paid And Capex Coverage Ratio4.825.068920.898
Slightly volatile
Net Income Per E B T0.821.10590.9955
Pretty Stable
Cash Ratio0.110.1170.7109
Very volatile
Days Of Inventory Outstanding1.411.340.2828
Slightly volatile
Days Of Sales Outstanding46.6179.696348.2364
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.91.19731.0572
Pretty Stable
Fixed Asset Turnover89.3810568.5076
Slightly volatile
Capital Expenditure Coverage Ratio4.825.068920.898
Slightly volatile
Debt Ratio0.02260.02380.1467
Slightly volatile
Price Sales Ratio1.131.188911.54
Slightly volatile
Asset Turnover2.192.47941.9915
Very volatile
Gross Profit Margin0.01180.01240.0362
Pretty Stable

Agilon Fundamental Market Drivers

Forward Price Earnings204.0816
Cash And Short Term Investments495.1 M

Agilon Upcoming Events

6th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Agilon Health Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Agilon Health income statement, its balance sheet, and the statement of cash flows. Agilon Health investors use historical funamental indicators, such as Agilon Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Agilon Health investors may use each financial statement separately, they are all related. The changes in Agilon Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Agilon Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Agilon Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Agilon Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-970.9 M-922.4 M
Total Revenue4.3 B2.4 B
Cost Of Revenue4.3 B2.3 B
Stock Based Compensation To Revenue 0.02  0.03 
Sales General And Administrative To Revenue 0.07  0.06 
Capex To Revenue(0.01)(0.01)
Revenue Per Share 10.56  11.08 
Ebit Per Revenue(0.05)(0.06)

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as agilon health using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Information and Resources on Investing in Agilon Stock

When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports:
Check out the analysis of Agilon Health Correlation against competitors.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
11.951
Earnings Share
(0.49)
Revenue Per Share
11.931
Quarterly Revenue Growth
0.522
Return On Assets
(0.07)
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.